Yılmaz, Y. 2025. Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis. FRONTIERS IN PHARMACOLOGY , vol.16 .

Yılmaz, Y., (2025). Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis. FRONTIERS IN PHARMACOLOGY , vol.16.

Yılmaz, YUSUF. "Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis," FRONTIERS IN PHARMACOLOGY , vol.16, 2025

Yılmaz, YUSUF. "Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis." FRONTIERS IN PHARMACOLOGY , vol.16, 2025

Yılmaz, Y. (2025) . "Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis." FRONTIERS IN PHARMACOLOGY , vol.16.

@article{article, author={YUSUF YILMAZ}, title={Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis}, journal={FRONTIERS IN PHARMACOLOGY}, year=2025}